Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.

These findings demonstrate the involvement of the ANS in psychedelic-induced peak experiences and may pave the way to the development of biofeedback-based tools to enhance psychedelic therapy.